ADAR1 Capital Management’s OnKure Therapeutics OKUR Stock Holding History

ADAR1 Capital Management’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.2M	Sell	2,238,684 -196,257	-8%	-$842K	0.47%	52
2026 Q1	$10.1M	Buy	2,434,941 +1,420,783	+140%	+$4.39M	0.59%	46
2025 Q4	$2.94M	Buy	+1,014,158	New	+$3.04M	0.22%	82
2025 Q3	–	Sell	-10,000	Closed	-$23.9K	–	270
2025 Q2	$23.9K	Hold	10,000	–	–	﹤0.01%	198
2025 Q1	$43K	Buy	+10,000	New	+$56.2K	0.01%	183
2024 Q1	–	Sell	-4,000	Closed	-$64K	–	292
2023 Q4	$64K	Buy	+4,000	New	+$249K	0.02%	106

Other funds holding OKUR

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ADAR1 Capital Management's OKUR Position: Q2 2026 in Review

ADAR1 Capital Management reduced its OnKure Therapeutics (OKUR) stake by 8.1% in Q2 2026, selling an estimated $842K and leaving 2,238,684 shares worth $10.2M. The position accounts for 0.47% of the portfolio, ranked #52.

ADAR1 Capital Management first reported a position in OKUR in Q4 2023 and has held it in 6 quarters since. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

ADAR1 Capital Management held 2,238,684 shares of OnKure Therapeutics worth $10.2M as of Q2 2026.
ADAR1 Capital Management sold 196,257 OnKure Therapeutics shares in Q2 2026, an estimated $842K.
OnKure Therapeutics made up 0.47% of ADAR1 Capital Management's portfolio in Q2 2026, its #52 holding.
ADAR1 Capital Management first reported a position in OnKure Therapeutics in Q4 2023 and has held it in 6 quarters since.
75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.